PO.CL11.02 · 临床研究
癌症幸存者对基于技术的压力管理和有效沟通工具的接受度
Cancer survivors' acceptance of technology-based tools for stress management and effective communication
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
癌症幸存者需要处理复杂的诊断和治疗信息,使得就医预约成为一种压力来源。对医疗决策的不确定性加重了压力,限制了就诊期间的沟通质量。人工智能(AI)工具正逐渐成为增强患者支持的方法,但在讲西班牙语的癌症幸存者中的应用仍然有限。本研究旨在刻画波多黎各癌症幸存者的压力水平,并评估其在与医生会面前的准备程度。我们还评估了他们对使用技术进行压力管理和与医生沟通的开放态度。我们假设幸存者会报告高压力水平、低准备程度和对技术的接受度。在这项横断面研究中,169名年龄≥21岁的癌症幸存者在肿瘤科候诊室于其就诊前被招募。在知情同意后,他们完成了一份调查,以评估压力、准备程度和对技术的开放态度。测量了过去30天内、就诊前以及关于本次就诊的压力水平。就诊准备程度采用1-10分量表评估,并询问他们是否为医生准备了一份问题清单。对技术的开放态度通过以下问题评估:是否愿意使用手机/平板进行放松练习,以及是否愿意以电子方式提交问题供医生在就诊前阅读。统计分析使用R进行。采用描述性统计评估关注变量。大多数研究参与者(68.6%)为女性;平均年龄57.8岁(SD=14.5)。癌症诊断时的平均年龄为55岁(SD=14.7)。就诊原因包括常规随访(61.7%)、检查结果讨论(9%)、首次就诊(9%)和新症状随访(4.2%)。超过三分之一(36.3%)报告在过去30天内通常/总是感到压力,55.6%报告就诊前有压力,53%对本次就诊有压力。尽管自我报告的平均准备评分为8.4分(满分10分)且92%表示他们感到已为就诊做好准备,但只有27%写下了一份问题清单来引导与医生的对话。至于对基于技术的工具的接受度,68%表示他们会从就诊前的压力管理练习中获益,66%愿意以电子方式向医生发送问题。在不愿意的人中,最常见的原因是偏好面对面讨论(27.2%)。压力可能损害记忆,干扰幸存者在就诊期间提问的意图。研究结果证实了癌症幸存者就诊前的高压力,以及书写问题以辅助沟通的低倾向。这凸显了需要制定策略来增强情绪就绪度和准备程度。结果表明幸存者对AI辅助的压力管理和改善医患沟通工具持开放态度,支持将其整合到标准癌症护理中。
查看英文原文 English abstract
Cancer survivors process complex diagnosis and treatment information making medical appointments a source of stress. Uncertainty about medical decisions heightens stress limiting quality of communication during appointments. Artificial intelligence (AI) tools are emerging as approaches to enhance patient support yet use with Spanish-speaking cancer survivors is limited. This study sought to characterize stress levels of Puerto Rican cancer survivors and assess preparedness before meeting with physicians. We also assessed openness to use technology for stress management and communication with physicians. We hypothesized survivors would report high stress levels, low preparedness, and acceptance of technology. In this cross-sectional study, 169 cancer survivors aged ≥21 were recruited prior to their appointment in oncology waiting rooms. Upon consenting, they completed a survey to assess stress, preparedness, and openness to technology. Stress levels in the past 30 days, prior to appointments, and regarding the current visit were measured. Preparedness for the visit was assessed with a 1-10 scale and asking if they had prepared a list of questions for their physicians. Openness to technology was assessed with questions about willingness to: use a phone/tablet for a relaxation exercise and submit questions electronically for physicians to read before appointments. Statistical analyses were performed using R. Descriptive statistics were used to assess variables of interest. Most study participants (68.6%) were women; mean age 57.8 (SD=14.5). Average age at cancer diagnosis was 55 (SD=14.7). Reasons for visit included routine follow-up (61.7%), test results discussion (9%), first appointment (9%), and follow-up for new symptoms (4.2%). More than a third (36.3%) reported usually/always feeling stress in the past 30 days, 55.6% reported stress prior to appointments, and 53% about their current visit. Despite an average self-reported preparation score of 8.4 (out of 10) and 92% indicating they felt prepared for the visit, only 27% had written a list of questions to guide the conversation with their physician. As for acceptance to technology-based tools, 68% indicated they would benefit from a stress management exercise before appointments and 66% were willing to send questions electronically to their physicians. Among those unwilling, the most common reason was preference for in-person discussion (27.2%). Stress may impair memory interfering with survivors' intentions to ask questions during visits. Findings confirm high pre-appointment stress among cancer survivors and a low tendency to write questions to aid communication. This highlights a need for strategies to enhance emotional readiness and preparedness. Results suggest openness to AI-assisted tools for stress management and improved patient-physician communication, supporting its integration into standard cancer care.
利益披露 Disclosure
A. C. Sala, None..
L. Castro Jimenez, None..
E. Ivanovich-Méndez, None..
B. Torres, None..
Z. Tamarit, None..
M. Soto-Salgado, None..
V. Colón-López, None.